Samsung Biologics acquires PolyPeptide Group for 2.7 trillion won ($1.8 billion)
Source: CNBC Top News — This article was automatically imported from the source. Read full article at original source →
Samsung Biologics to acquire Switzerland’s PolyPeptide Group in $1.8 billion all-cash deal
Originally published by
CNBC Top News
cnbc.com
Visit original article
